Chlorphenoxamine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H22ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3UVD77BP8R, chemically known as 2-(1-(p-chlorophenyl)-1-phenylethoxy)-n,n-dimethylethylamine but generally known as chlorphenoxamine, which bears US NIH Compound Identifier 6475. European Medicines Agency schedules Chlorphenoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06204MIG. The term CHLORPHENOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules chlorphenoxamine in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORPHENOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorphenoxamine under HS 29221980 and SITC 51461. As of Q4 2014, CHLORPHENOXAMINE remains the US FDA Preferred Term for this commodity. Chlorphenoxamine bears US NLM identifiers UMLS ID C0055468 and NCI Concept Code C81131. SMILES: CLC1CCC(C(OCCN(C)C)(C2CCCCC2)C)CC1.